Kirin Brewery Co., Ltd.  Exclusive distributor of TC Mouse containing all of the human antibody genes.

Athersys, Inc.  A collaboration to develop novel therapeutics produced through the joint application of Medarex's HuMAb Mouse® technology and Athersys' RAGE technology. The companies plan to jointly discover, develop and commercialize fully human antibodies as therapeutics.

Eos Biotechnology, Inc.  Applied genomics partnership to develop human antibodies against disease targets.

Johnson & Johnson  Broad HuMAb-Mouse antibody development agreement.

LeukoSite (Acquired by Millennium Pharmaceuticals)  Broad HuMAb-Mouse antibody development agreement.

Novartis Corporation  Broad HuMAb-Mouse antibody development agreement.

IDM S.A.  Broad HuMAb-Mouse antibody development agreement and Anti-CTLA-4 cancer vaccine development.

Biosite Incorporated  Trans-Phage Technology, high-throughput human antibody development for genomic target validation.

Ambit Biosciences  Co-development of Antibody therapeutics for targets discovered by Ambit

ImmunoGen, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Raven Biotechnologies, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Eli Lilly and Company 

Bristol-Myers Squibb Company 

Abbott Laboratories 

MedImmune 

Regeneron Pharmaceuticals, Inc.  Applied genomics partnership to develop human antibodies against disease targets.